Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1 169 in patients with metastatic castrate-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Morris, M. J.; Vogelzang, N.; Sartor, O.; Armour, A.; Groaning, M.; Robarts, A.; Petrylak, D. P.; Tolcher, A. W.; Gordon, M. S.; Babiker, H. M. |
| Abstract Title: | Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1 169 in patients with metastatic castrate-resistant prostate cancer (mCRPC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 272s |
| Language: | English |
| ACCESSION: | WOS:000411931703028 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.5038 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5038 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work